Cite
HARVARD Citation
Yu, Z. et al. (n.d.). RAD140, an orally available selective androgen receptor modulator, exhibits potent anti-tumor activity in ER+AR+ breast cancer models. European journal of cancer. pp. S149-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yu, Z. et al. (n.d.). RAD140, an orally available selective androgen receptor modulator, exhibits potent anti-tumor activity in ER+AR+ breast cancer models. European journal of cancer. pp. S149-. [Online].